RLMD ▲ +2.7% - Relmada Therapeutics, Inc. $RLMD - Relmada Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference Relmada Therapeutics gained 2.7% today following an announcement that the company will participate at the Wells Fargo 21st Annual Healthcare Conference. Conference participation often provides a platform for companies to present clinical progress and investor updates to institutional audiences. 01-SEP-2026 08:00 AM ET